These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson's disease. Papadopoulos VE; Nikolopoulou G; Antoniadou I; Karachaliou A; Arianoglou G; Emmanouilidou E; Sardi SP; Stefanis L; Vekrellis K Hum Mol Genet; 2018 May; 27(10):1696-1710. PubMed ID: 29547959 [TBL] [Abstract][Full Text] [Related]
25. Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection. Carmo-Gonçalves P; Coelho-Cerqueira E; de Araujo Lima V; Follmer C Expert Rev Neurother; 2023 Apr; 23(4):321-330. PubMed ID: 37016954 [TBL] [Abstract][Full Text] [Related]
26. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation. Buell AK; Galvagnion C; Gaspar R; Sparr E; Vendruscolo M; Knowles TP; Linse S; Dobson CM Proc Natl Acad Sci U S A; 2014 May; 111(21):7671-6. PubMed ID: 24817693 [TBL] [Abstract][Full Text] [Related]
34. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease. Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021 [TBL] [Abstract][Full Text] [Related]
35. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Conway KA; Harper JD; Lansbury PT Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204 [TBL] [Abstract][Full Text] [Related]
36. Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents. Polinski NK; Volpicelli-Daley LA; Sortwell CE; Luk KC; Cremades N; Gottler LM; Froula J; Duffy MF; Lee VMY; Martinez TN; Dave KD J Parkinsons Dis; 2018; 8(2):303-322. PubMed ID: 29400668 [TBL] [Abstract][Full Text] [Related]
37. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity. Vinueza-Gavilanes R; Íñigo-Marco I; Larrea L; Lasa M; Carte B; Santamaría E; Fernández-Irigoyen J; Bugallo R; Aragón T; Aldabe R; Arrasate M Neurobiol Dis; 2020 Apr; 137():104781. PubMed ID: 31991248 [TBL] [Abstract][Full Text] [Related]
38. Different Structural Conformers of Monomeric α-Synuclein Identified after Lyophilizing and Freezing. Stephens AD; Nespovitaya N; Zacharopoulou M; Kaminski CF; Phillips JJ; Kaminski Schierle GS Anal Chem; 2018 Jun; 90(11):6975-6983. PubMed ID: 29750859 [TBL] [Abstract][Full Text] [Related]
39. Assessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy. Gonçalves S; Outeiro TF Mol Neurobiol; 2013 Jun; 47(3):1081-92. PubMed ID: 23389286 [TBL] [Abstract][Full Text] [Related]
40. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Cullen V; Lindfors M; Ng J; Paetau A; Swinton E; Kolodziej P; Boston H; Saftig P; Woulfe J; Feany MB; Myllykangas L; Schlossmacher MG; Tyynelä J Mol Brain; 2009 Feb; 2():5. PubMed ID: 19203374 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]